Abstract
The Chinese chemistry service provider Raybow Pharmaceutical has acquired PharmAgra Labs, a custom chemical R&D firm based in Brevard, North Carolina. Raybow CEO Bin Wang says the purchase brings his firm closer to its growing US customer base. Raybow’s main facility is in Taizhou, China. Its parent company, Zhejiang Jiuzhou Pharmaceutical, is in the process of acquiring a Novartis pharmaceutical chemical plant in Suzhou, China.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.